Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02654639
Title Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Georgetown University
Indications

colorectal cancer

Therapies

Bevacizumab + Trifluridine-tipiracil hydrochloride

Age Groups: adult
Covered Countries USA


No variant requirements are available.